Experienced in Infectious Myocarditis

Christophe Piot

Montpellier, FR 
Experienced in Infectious Myocarditis
Montpellier, FR 
OverviewLocationsClinical Research

Overview

Christophe Piot practices in Montpellier, France. Mr. Piot is rated as an Experienced expert by MediFind in the treatment of Infectious Myocarditis. His top areas of expertise are Heart Attack, Cardiac Tamponade, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Patent Foramen Ovale Repair.

His clinical research consists of co-authoring 61 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Montpellier, France
Other Locations
Villeurbanne, France
INSERM 894, INSERM 1148, University Paris Est Creteil, INSERM 894, INSERM 1191, Dijon Stroke Registry, EA 7460, INSERM 1059, INSERM 1078, Lens, France
Ollioules, 83190, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Multicentre Randomized Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation.
Multicentre Randomized Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation.
Enrollment Status: Completed
Publish Date: September 04, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
The REDUCE FMR Trial: Safety and Efficacy of the Carillon Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure
The REDUCE FMR Trial: Safety and Efficacy of the Carillon Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure
Enrollment Status: Completed
Publish Date: August 05, 2024
Intervention Type: Device
Study Phase: Not Applicable
Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions - an Open, Multicenter Randomized Controlled Trial With Two Parallel Arms (1:1)
Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions - an Open, Multicenter Randomized Controlled Trial With Two Parallel Arms (1:1)
Enrollment Status: Completed
Publish Date: July 24, 2024
Intervention Type: Drug
Study Phase: Phase 4
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Enrollment Status: Unknown
Publish Date: October 08, 2019
View 3 Less Clinical Trials

61 Total Publications

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction.
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction.
Journal: The New England journal of medicine
Published: September 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Piot's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile